{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:10:57Z","timestamp":1787847057797,"version":"build-2784847793"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00401-022-02515-3","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T07:03:27Z","timestamp":1667545407000},"page":"149-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target"],"prefix":"10.1007","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0332-1673","authenticated-orcid":false,"given":"L. S.","family":"Hiemcke-Jiwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Dierselhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Haveman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. W. J.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. B. J.","family":"Tops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"van Gorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Y.","family":"Hehir-Kwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. A. E. M.","family":"van Belzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Bonenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"van Noesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Flucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"2515_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/gcc.22846","volume":"59","author":"CR Antonescu","year":"2020","unstructured":"Antonescu CR (2020) Emerging soft tissue tumors with kinase fusions: an overview of the recent literature with an emphasis on diagnostic criteria. Genes Chromosomes Cancer 59:437\u2013444","journal-title":"Genes Chromosomes Cancer"},{"key":"2515_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A (2018) NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 15:731\u2013747","journal-title":"Nat Rev Clin Oncol"},{"key":"2515_CR3","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/s41591-019-0542-z","volume":"25","author":"E Cocco","year":"2019","unstructured":"Cocco E, Schram AM, Kulick A, Misale S, Won HH, Yaeger R et al (2019) Resistance to TRK inhibition mediated by convergent MAPK pathway activation. Nat Med 25:1422\u20131427","journal-title":"Nat Med"},{"key":"2515_CR4","doi-asserted-by":"publisher","unstructured":"de Blank PMK, Gross AM, Akshintala S, Blakeley JO, Bollag G, Cannon A et al (2022) MEK inhibitors for neurofibromatosis type 1 manifestations: clinical evidence and consensus. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noac165","DOI":"10.1093\/neuonc\/noac165"},{"key":"2515_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ymthe.2018.10.022","volume":"27","author":"C Dupain","year":"2019","unstructured":"Dupain C, Harttrampf AC, Boursin Y, Lebeurrier M, Rondof W, Robert-Siegwald G et al (2019) Discovery of new fusion transcripts in a cohort of pediatric solid cancers at relapse and relevance for personalized medicine. Mol Ther 27:200\u2013218","journal-title":"Mol Ther"},{"key":"2515_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1200\/PO.19.00287","volume":"4","author":"ML Hemming","year":"2020","unstructured":"Hemming ML, Nathenson MJ, Lin JR, Mei S, Du Z, Malik K et al (2020) Response and mechanisms of resistance to larotrectinib and selitrectinib in metastatic undifferentiated sarcoma harboring oncogenic fusion of NTRK1. JCO Precis Oncol 4:79\u201390","journal-title":"JCO Precis Oncol"},{"key":"2515_CR7","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.1038\/s41598-021-85055-2","volume":"11","author":"JF Longo","year":"2021","unstructured":"Longo JF, Brosius SN, Znoyko I, Alers VA, Jenkins DP, Wilson RC et al (2021) Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line. Sci Rep 11:5690","journal-title":"Sci Rep"},{"key":"2515_CR8","first-page":"i50","volume":"2","author":"A Pemov","year":"2020","unstructured":"Pemov A, Li H, Presley W, Wallace MR, Miller DT (2020) Genetics of human malignant peripheral nerve sheath tumors. Neurooncol Adv 2:i50\u2013i61","journal-title":"Neurooncol Adv"},{"key":"2515_CR9","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41388-022-02290-1","volume":"41","author":"BN Somatilaka","year":"2022","unstructured":"Somatilaka BN, Sadek A, McKay RM, Le LQ (2022) Malignant peripheral nerve sheath tumor: models, biology, and translation. Oncogene 41:2405\u20132421","journal-title":"Oncogene"},{"key":"2515_CR10","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionp\u00e4\u00e4 RA, P\u00f6yh\u00f6nen M, Lepp\u00e4virta J, Yl\u00e4-Outinen H et al (2016) Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol 34:1978\u20131986","journal-title":"J Clin Oncol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-022-02515-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-022-02515-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-022-02515-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T11:18:18Z","timestamp":1672658298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-022-02515-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2515"],"URL":"https:\/\/doi.org\/10.1007\/s00401-022-02515-3","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"16 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Code of Conduct for Medical Research of the Federation of the Dutch Medical Scientific Societies. In addition, the material acquisition was performed in accordance with local bio banking initiative.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}